Data clean room software provider, Habu, announces acquisition agreement by LiveRamp, the leading data collaboration platform.
Law360 quotes Joe Green in its article, "3 Factors Firms Must Consider Before Building Gen AI Apps."
Global leader in data integration, analytics, and AI, Qlik, announced its acquisition of pivotal intellectual property from Kyndi, an innovator in natural language processing, search and generative AI.
The annual deadline for filing certain initial Schedules 13G, an amendment to a previously filed Schedule 13G, an initial Form 13F filing, and an annual update to a previously filed Form 13H with the Securities and Exchange Commission (the “SEC”) for the year ended December 31, 2023 is Wednesday, February 14, 2024.
Gunderson Dettmer's Life Sciences Group participated across events during the 2024 JPM Healthcare Conference. The JP Morgan Healthcare Conference is the largest and most informative healthcare investment symposium, which connects global industry leaders, emerging fast-growth companies, innovative technology creators, and investment community members.
Partners Brian Hutchings and Ben Buckwalter hosted the webinar, “How the SEC’s Private Fund Adviser Rules and Other Recent Developments Will Affect VCs in LatAm” to discuss the U.S. Securities and Exchange Commission rules and how they are relevant to fund managers focused on the Latin America region.
Fast Company quoted Katie Gardner in its article on The New York Times lawsuit against OpenAI and Microsoft, challenging the fair use of copyrighted data used to train language models like ChatGPT.
Natalie Pierce is quoted in WorkLife's article on the significant development in state laws regarding protected leaves.
Gunderson Dettmer São Paulo founding partner Brian Hutchings is featured in Época NEGÓCIOS article, "What are the prospects for the Venture Capital market in Latin America in 2024"
Genomic medicine company, Moonwalk Biosciences, announced its Series A and Seed financings totaling $57 million to continue reprogramming cells to their healthy state.
Life sciences-focused investment firm TCG Crossover announces its $1 billion TCG Crossover Fund II to invest in exceptional entrepreneurs focused on developing better treatment options for patients.
Partner Katie Gardner is quoted in AdWeek's article on the future of AI for publishers.
Clinical-stage biotechnology company, Remix Therapeutics, announces its $60 million financing.
The recent emergence of sophisticated artificial intelligence (AI) technologies with far-reaching use cases has opened up new opportunities for companies across industries. But as has been the case with many rapidly developing technologies, AI also creates new risks or heightens existing risks for many companies.
Ivan Gaviria is quoted in Fortune's article on the 2024 predictions for artificial intelligence.
Natalie Pierce is quoted in HR Brew's article on the surge of AI tools in the HR tech space.
Clinical stage biotechnology company, Remix Therapeutics, announces collaboration and licensing agreement with Roche for the discovery and development of small molecule therapeutics that modulate RNA processing.
Katie Gardner is quoted in TechTarget's article to share her insight on the New York Times' AI lawsuit.
8 individuals at Gunderson Dettmer clients were recognized in Venture Capital Journal's 2024 Rising Stars list.
Public companies remain required to report share repurchase information consistent with existing requirements
On December 19, 2023, a panel of the U.S. Court of Appeals for the Fifth Circuit vacated the share repurchase disclosure rules adopted by the U.S. Securities and Exchange Commission (SEC) in May 2023. The rules would have imposed new and expanded quantitative and qualitative disclosure obligations on public companies about repurchases of their equity securities (commonly referred to as buybacks), including quarterly reporting in Form 10-K and Form 10-Q reports of daily share repurchase activity and company Rule 10b5-1 trading plans used to execute share repurchases
HR Brew featured partner Natalie Pierce to share the best usages for generative AI in HR.
Leader in AI-driven fulfillment automation, GreyOrange, announces its $135 million Series D financing to accelerate the company's technology leadership.
LawNext's article quoted Gunderson chief innovation officer Joe Green in its article on the latest updates on ChatGD.
Leader in photonics, Lightmatter, announced its $155 million Series C-2 financing, which brings the company’s valuation to over $1.2 billion.
Katie Gardner was quoted in MIT technology Review's article on generative AI's future.
Current reporting about material cybersecurity incidents within four business days pursuant to new Item 1.05 of Form 8-K required beginning on December 18, 2023 for public companies other than smaller reporting companies (June 15, 2024 for smaller reporting companies)
Gunderson Dettmer’s Singapore office continues to earn top rankings in Startups & Emerging Companies (Singapore) in the newly released Chambers and Partners Asia-Pacific 2024 guide. Singapore managing partner Jonathan Pentzien is ranked a Band 1 Leading Individual for the fourth consecutive year, and partner David He, who was newly ranked Up and Coming in 2023, moved up to Band 5.
Headline leads the BRL 70 million Series B financing of Trinus Co, a financial and real estate service platform.
On January 1, 2024, California will begin enforcing two new laws that expand the state’s already-stringent restrictions on non-compete clauses in employment agreements.
Gunderson Dettmer has elected seven new partners, effective January 1, 2024. These newly promoted partners serve clients throughout the innovation economy from several of the firm’s core practices: Corporate & Securities, Fund Formation, Mergers & Acquisitions and Strategic Transactions & Licensing.
- Page 5 of 53